Urinary Metabolomics Study of Patients with Gout Using Gas Chromatography-Mass Spectrometry

Abstract

Objectives Gout is a common type of inflammatory arthritis. The aim of this study was to detect urinary metabolic changes in gout patients which may contribute to understanding the pathological mechanism of gout and discovering potential metabolite markers. Methods Urine samples from 35 gout patients and 29 healthy volunteers were analyzed by gas chromatography–mass spectrometry (GC–MS). Orthogonal partial least-squares discriminant analysis (OPLS-DA) was performed to screen differential metabolites between two groups, and the variable importance for projection (VIP) values and Student's t-test results were combined to define the significant metabolic changes caused by gout. Further, binary logistic regression analysis was performed to establish a model to distinguish gout patients from healthy people, and receiver operating characteristic (ROC) curve was made to evaluate the potential for diagnosis of gout. Result A total of 30 characteristic metabolites were significantly different between gout patients and controls, mainly including amino acids, carbohydrates, organic acids, and their derivatives, associated with perturbations in purine nucleotide synthesis, amino acid metabolism, purine metabolism, lipid metabolism, carbohydrate metabolism, and tricarboxylic acid cycle. Binary logistic regression and ROC curve analysis showed the combination of urate and isoxanthopterin can effectively discriminate the gout patients from controls with the area under the curve (AUC) of 0.879. Conclusion Thus, the urinary metabolomics study is an efficient tool for a better understanding of the metabolic changes of gout, which may support the clinical diagnosis and pathological mechanism study of gout.

NMR-Based Metabonomic Study Reveals Intervention Effects of Polydatin on Potassium Oxonate-Induced Hyperuricemia in Rats

“…Previous studies have consistently demonstrated the dysfunctional energy metabolism in patients with hyperuricemia as well as in animal models [ 22 , 24 – 26 ]. Important tricarboxylic acid (TCA) cycle intermediate metabolites such as succinate, citrate, and fumarate were downregulated in urine of gout patients and hyperuricemic mouse [ 27 , 28 ]. Hyperuricemic rats in our study exhibited an elevated level of β -glucose in serum together with a decreased level of succinate in urine as compared with normal rats.…”

VISSA-PLS-DA-Based Metabolomics Reveals a Multitargeted Mechanism of Traditional Chinese Medicine for Traumatic Brain Injury

“…Survivors of TBI commonly live with neurocognitive deficits and physical disability and increased risk of neurodegenerative disease in the long term (Pattinson and Gill, 2018). Unfortunately, no drug has been approved in Phase III of clinical trials for treating TBI (Stocchetti et al., 2015) because of complex pathogenesis, such as burst reactive oxygen species, increased glutamate levels, destroyed blood–brain barrier (BBB), uncontrolled neuroinflammation, and obliterated synapse (Li et al., 2018; Ma et al., 2018; Ichkova et al., 2019). Thus, the consensus of multitarget intervention was formed as its therapeutic principle.…”

Clinical characteristics and gene mutation analysis of an adult patient with ETFDH‑related multiple acyl‑CoA dehydrogenase deficiency

“…In the past, the diagnosis of MADD could be quickly and easily achieved using tandem mass spectrometry of blood samples, which could be further confirmed by gas chromatography mass spectrometry analysis of urine organic acids ( 21 , 22 ). However, in late-onset patients, the increased levels of acylcarnitines and urinary organic acids may be mild and atypical, or detectable only during acute episodes ( 5 , 17 ), therefore, genetic analysis to detect mutations in the ETF or ETFDH genes is considered as the key method for a definitive diagnosis.…”